U.S. FDA Approves TECVAYLI™ (teclistamab-cqyv), the First Bispecific T-cell Engager Antibody for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma
It's no secret I'm a Minnesota Vikings fan. My fandom started in the late 60s. From 1969 to 1975, the Vikings were in 4 Super Bowls...
Post a Comment